MedTrace Logo

Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation

NCT03037398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-04-03

No results posted yet for this study

Summary

The objective of this study is to evaluate the performance of novel DBS programming methods compared to traditional programming methods.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Vercise Deep Brain Stimulation System

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Natalie Bloom Lyons · Boston Scientific Neuromodulation Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-11
Primary Completion
2025-04-02
Completion
2025-04-02

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03037398 on ClinicalTrials.gov